Laothamatas, K., Benvenuto, L., Raval, M., Kim, F., Lemaitre, P. H., Sonett, J. R., & Arcasoy, S. M. (2025). Successful Lung Transplantation in A Patient With Pre-Existing Chronic Myeloid Leukemia Treated With Imatinib: A Case Report. Transplantation Proceedings, 57(3), 491–494. https://doi.org/10.1016/j.transproceed.2025.02.020

Brivio, E., Pennesi, E., Willemse, M. E., Huitema, A. D. R., Jiang, Y., van Tinteren, H. D. R., van der Velden, V. H. J., Beverloo, B. H., den Boer, M. L., Rammeloo, L. A. J., Hudson, C., Heerema, N., Kowalski, K., Zhao, H., Kuttschreuter, L., Bautista Sirvent, F. J., Bukowinski, A., Rizzari, C., Pollard, J., … Zwaan, C. M. (2024). Bosutinib in Resistant and Intolerant Pediatric Patients With Chronic Phase Chronic Myeloid Leukemia: Results From the Phase I Part of Study ITCC054/COG AAML1921. Journal of Clinical Oncology, 42(7), 821–831. https://doi.org/10.1200/jco.23.00897

Menger, J. M., Sathianathen, R. S., Sakamoto, K. M., & Hijiya, N. (2024). BCR/ABL-Positive Chronic Myeloid Leukemia in Children: Current Treatment Approach. Current Oncology Reports, 26(3), 250–257. https://doi.org/10.1007/s11912-024-01502-z

Lee, M. H., Song, A., & Li, J. Y. (2024). Erythroid variant evolving from chronic myeloid leukemia resistant to multiple tyrosine kinase inhibitors: a rare case report. Diagnostic Pathology, 19(1). https://doi.org/10.1186/s13000-024-01446-9

Hijiya, N., Maschan, A., Rizzari, C., Shimada, H., Dufour, C., Goto, H., Kang, H. J., Guinipero, T., Karakas, Z., Bautista, F., Ducassou, S., Yoo, K. H., Zwaan, C. M., Millot, F., Patterson, B. C., Samis, J., Izquierdo, M., Titorenko, K., Li, S., & Sosothikul, D. (2023). The long-term efficacy and safety of nilotinib in pediatric patients with CML: a 5-year update of the DIALOG study. Blood Advances, 7(23), 7279–7289. https://doi.org/10.1182/bloodadvances.2023010122

Williams, O., Hu, L., Huang, W., Patel, P., Bartom, E. T., Bei, L., Hjort, E., Hijiya, C., & Eklund, E. A. (2023). Nore1 inhibits age-associated myeloid lineage skewing and clonal hematopoiesis but facilitates termination of emergency (stress) granulopoiesis. Journal of Biological Chemistry, 299(7), 104867. https://doi.org/10.1016/j.jbc.2023.104867

Sembill, S., Ampatzidou, M., Chaudhury, S., Dworzak, M., Kalwak, K., Karow, A., Kiani, A., Krumbholz, M., Luesink, M., Naumann-Bartsch, N., De Moerloose, B., Osborn, M., Schultz, K. R., Sedlacek, P., Giona, F., Zwaan, C. M., Shimada, H., Versluijs, B., Millot, F., … Metzler, M. (2023). Management of children and adolescents with chronic myeloid leukemia in blast phase: International pediatric CML expert panel recommendations. Leukemia, 37(3), 505–517. https://doi.org/10.1038/s41375-023-01822-2

Ford, M., Mauro, M., Aftandilian, C., Sakamoto, K. M., & Hijiya, N. (2022). Management of Chronic Myeloid Leukemia in Children and Young Adults. Current Hematologic Malignancy Reports, 17(5), 121–126. https://doi.org/10.1007/s11899-022-00673-5

Smith, S. M., Zhang, S., Sundaram, V., Roth, M., Andolina, J. R., Schapira, L., Sakamoto, K. M., Kolb, E. A., Hijiya, N., & Chaudhury, S. (2021). Physician risk perceptions and surveillance practices for tyrosine kinase inhibitor long-term effects in pediatric CML. Pediatric Hematology and Oncology, 39(5), 453–467. https://doi.org/10.1080/08880018.2021.2017085